Martek
This article was originally published in The Tan Sheet
Executive Summary
International expansion boosts Q3 nutritional product sales to $4.9 mil., up 166% from last year's third quarter, firm says during Sept. 13 analysts call. Company's licensed products are now in 25 countries, five more than reported in second quarter. Clinical studies are underway to examine DHA's effects on women with bipolar disorder and on the cardiovascular system, company says. Total revenues for the quarter ended July 31 were up 127% to $5.6 mil.; net loss of $3.3 mil. was an improvement upon $3.8 mil. net loss during the year-ago quarter